期刊文献+

去整合素Echistatin抑制糖尿病兔远期后发性白内障 被引量:2

Different concentrations of disintegrin Echistatin in inhibition of long-term posterior capsule opacification in diabetic rabbit
下载PDF
导出
摘要 目的观察并探讨不同浓度去整合素(Echistatin,Ecs)对糖尿病兔远期后发性白内障(posterior capsular opacification,PCO)发生过程中晶状体上皮细胞(lens epithelial cells,LEC)增殖的抑制作用,以及其在眼内的安全性。方法建立糖尿病兔模型,随机分为对照组(A组,术毕前房注入蒸馏水0.2 mL);实验组:B组、C组、D组(术毕前房分别注入5.0×10-3μg·L-1、7.5×10-3μg·L-1、10.0×10-3μg·L-1Ecs),术后裂隙灯下观察角膜、前房及PCO情况。术后6周取材,常规石蜡切片,HE染色。用免疫组织化学法检测PCO发生过程中LEC增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)的表达,TUNEL法检测角膜内皮细胞、视网膜神经节细胞层及内核层细胞的凋亡情况。结果 HE染色结果显示,术后6周各组角膜内皮细胞排列整齐、未见水肿,视网膜内界膜与各层组织结构完整,未见药物引起明显的组织损伤反应。各组间PCO分级差异有统计学意义(P=0.011)。免疫组织化学法检测各组后囊膜PCNA表达结果显示,A组、B组、C组、D组的平均光密度值分别为0.499±0.043、0.484±0.055、0.422±0.012、0.340±0.031,B组后囊膜上PCNA表达与A组差异无统计学意义(P>0.05),余组间两两比较差异均有统计学意义(均为P<0.05)。TUNEL法检测各组角膜内皮细胞、视网膜神经节细胞层及内核层细胞凋亡发现,各组间细胞凋亡比较均未见明显差异(均为P>0.05)。结论 10.0×10-3μg·L-1Ecs对糖尿病兔远期PCO具有明显抑制作用,且对眼内相邻及重要组织无明显毒性作用,因此可选用此浓度进行后续研究。 Objective To observe the inhibitive effects of different concentrations of disintegrin Echistatin ( Ecs ) on lens epithelial cell ( LEC ) proliferation during long-term posterior capsular opacification(PCO)development,and discuss the safe concentration in the eyes of rabbits. Methods Diabetic rabbit models were established and randomly divided into control group (group A, surgery anterior chamber were injected 0.2 mL of distilled water)and experimental groups( group B, C and D, surgery anterior chamber were injected 0.2 mL Ecs of 5.0 × 10^-3 μg · L^-1 ,7.5 × 10^-3 μg · L^-1 , 10.0 × 10^-3 μg · L^-1, respectively). After injection, cornea, anterior chamber and PCO were observed under slit lamp. At postoperative 6 weeks, HE staining was performed, proliferating cell nuclear antigen(PCNA) expression in LEC during PCO development was observed by immunohistochemistry, and TUNEL assay was used to detect the apoptosis of corneal endothelial cells, retinal inner nuclear layer cells and ganglion cells. Resuits HE staining showed that the corneal endothelial cells arranged regularly with no edema, the structure of retinal internal limiting membrane and each layer of tissue were unchanged,no significant drug-induced damage tissue was appeared in each group at postoperative 5 weeks. There was statistical difference in PCO grading among groups (P =0. 011 ). Immunohistochemistry staining showed that the average optical density of PCNA expression in posterior capsule of group A, B, C and D were 0. 499 ±0. 043, 0.484 ±0. 055,0.422 ±0.012 and 0. 340 ±0.031 ,respectively,there were statistical differences between each two groups except for group A and group B( all P 〈 0.05 ). TUNEL method show that there was no statistical difference in the apoptosis of corneal endothelial cells, retinal hmer nuclear layer cells and ganglion cells between each two groups ( all P 〉 0.05 ). Conclusion Ecs with 10.0 × 10^-3 μg · L^-1 can not only obviously inhibit the development of long-term PCO in diabetic rabbits,but has no obvious toxic effects on intraocular adjacent tissues,so 10.0× 10^-3 μg · L^-1 Ecs can be used in further study.
出处 《眼科新进展》 CAS 北大核心 2014年第6期506-509,共4页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号:81160120)~~
关键词 去整合素 后发性白内障 增殖细胞核抗原 凋亡 糖尿病兔 disintegrin posterior capsular opacification proliferating cell nuclear antigen apoptosis diabetic rabbits
  • 相关文献

参考文献13

  • 1Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes meUitus[ J]. Am J Ophthalmol,2002,134( 1 ) :10-16.
  • 2周星,谭少健,粱皓,陈迎迎,李霞.去整合素echistatin对人晶状体上皮细胞增生、黏附、移行的影响[J].中华实验眼科杂志,2013,31(4):329-333. 被引量:4
  • 3韦琦,陈金卯,黄敏丽,李霞,何剑峰,谭少健.糖尿病兔晶状体后囊膜混浊模型的建立[J].中华实验眼科杂志,2011,29(2):130-134. 被引量:5
  • 4Odrich MG, Hall SJ, Worgul BV, Trokel SL, Rini FJ. Posterior capsule opacification: experimental analyses [ J ]. Ophthalmic Res. 1985.17 (2) :75-84.
  • 5丁文君,韦琦,梁皓,陈金卯,李霞,谭少健.糖尿病兔后发性白内障发生过程中晶状体上皮细胞增殖的变化[J].眼科新进展,2012,32(1):5-7. 被引量:6
  • 6Ebihara Y, Kato S, Oshika T, Yoshizak M, Sugita G. Posterior capsule opacification after cataract surgery in patients with dia- betes mellitus [ J ]. J Cataract Refrast Surg, 2006, 32 ( 7 ) : 1184-1187.
  • 7Nishi O, Nishi K, Fujiwara T, Shirasawa E, Ohmoto Y. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells[ J]. Br J Ophthalmol,1996, 80( 1 ) :63-68.
  • 8WedereU ED, Brown H, O' Connor M, Chamberlain G, McAvoy JW, de Iongh RU. Laminin-binding integrins in rat lens morpho- genesis and their regulation during fibre differentiation[ J]. Exp Eye Res ,2005,81 (3) :326-339.
  • 9张艳,王继红,刘欣,李庆伟.以整合素为作用靶点的精氨酸-甘氨酸-天冬氨酸模体毒素研究进展[J].国际药学研究杂志,2009,36(6):406-411. 被引量:4
  • 10Kim JT,Lee DH,Chung KH, Kang IC,Kim DS,Joo CK. Inhibitory effects of salmosin,a disintegrin, on posterior capsular opacifi- cation in vitro and in vivo [ J ]. Exp Eye Res , 2002,74 ( 5 ) : 585-594.

二级参考文献83

共引文献40

同被引文献33

  • 1王莉,李鹏.Nd∶YAG激光治疗后发性白内障的临床观察[J].国际眼科杂志,2005,5(4):768-770. 被引量:21
  • 2谭少健,梁皓,赵军,叶长华,胡启平.去整合素抑制体外培养的人眼晶状体上皮细胞生长的研究[J].广西医科大学学报,2006,23(3):348-351. 被引量:8
  • 3葛坚.眼科学[M].第2版.北京:人民卫生出版社,2010:307.
  • 4MEACOCK W R, SPALTON D J, STANFORD M R. Role of cytokines in the pathogenesis of posteriorcapsule opacifica- tion[ J ]. Br J Ophthalmo, 2000,84(3):332-336.
  • 5MCDONNELL P J, ROWENSL, GLASERBM, et al. Poste- rior capsule opacification An in vitro model[ J ]. Arch Oph- thalmol, 1985,103(9): 1 378-3 781.
  • 6SPONER U,PIEH S,SOLE1MAN A,et al. Upregulation of alphavbeta6 integrin, a potent TGF-betal activator, and posterior capsule opacification [ J ]. Cataract Refract Surg, 2005,31 (3):595-606.
  • 7ZHANGXH,JIJ,ZHANG H,et al. Detection of integrins in cataract lens epithelial cells [J ]. Cataract Refract Surg, 2000,26(2):287- 291.
  • 8KIM J T,LEE D H,CHUNG K H,et al. Inhibitory effects of salmosin,a disintegrin,on posterior capsular opacification in vitro and in vivo[J]. Exp Eye Res,2002,74(5): 585- 594.
  • 9NIBOURG LM, GELENS E, KUIJER R, HOOYMANS JM, VAN KOOTEN TG, KOOPMANS SA. Prevention of posterior capsu- lar opacification[J]. Exp Eye Res,2015,136(7) :100-115.
  • 10EBIHARA Y, KATO S, OSHIKA T, YOSHIZAKI M, SUG1TA G. Posterior capsule opacification after cataract surgery in pa- tients with diabetes mellitus [J]. J Cataract Refract Surg , 2006,32(7) :1184-1187.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部